Global Biosimilar Market Research Report 2020

Published Date : 2020-03-24

Category : Pharma & Healthcare

No. of Pages : 119


The global Biosimilar market is valued at US$ 6038.4 million in 2020 is expected to reach US$ 14790 million by the end of 2026, growing at a CAGR of 13.5% during 2021-2026.
This report focuses on Biosimilar volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Biosimilar market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Biosimilar market is segmented into
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others

Segment by Application
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others

Global Biosimilar Market: Regional Analysis
The Biosimilar market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Biosimilar market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Biosimilar Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Biosimilar market include:
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy’s Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer
Reliance Life Sciences

Table of Contents

1 Biosimilar Market Overview
1.1 Product Overview and Scope of Biosimilar
1.2 Biosimilar Segment by Type
1.2.1 Global Biosimilar Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Human Growth Hormones
1.2.3 Monoclonal Antibodies
1.2.4 Insulin
1.2.5 Peptides
1.2.6 Erythropoietin
1.2.7 Others
1.3 Biosimilar Segment by Application
1.3.1 Biosimilar Sales Comparison by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Chronic and Autoimmune Diseases
1.3.4 Growth Hormone Deficiency
1.3.5 Infectious Diseases
1.3.6 Others
1.4 Global Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Biosimilar Revenue 2015-2026
1.4.2 Global Biosimilar Sales 2015-2026
1.4.3 Biosimilar Market Size by Region: 2020 Versus 2026

2 Global Biosimilar Market Competition by Manufacturers
2.1 Global Biosimilar Sales Market Share by Manufacturers (2015-2020)
2.2 Global Biosimilar Revenue Share by Manufacturers (2015-2020)
2.3 Global Biosimilar Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Biosimilar Manufacturing Sites, Area Served, Product Type
2.5 Biosimilar Market Competitive Situation and Trends
2.5.1 Biosimilar Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Biosimilar Players (Opinion Leaders)

3 Biosimilar Retrospective Market Scenario by Region
3.1 Global Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Biosimilar Market Facts & Figures by Country
3.3.1 North America Biosimilar Sales by Country
3.3.2 North America Biosimilar Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biosimilar Market Facts & Figures by Country
3.4.1 Europe Biosimilar Sales by Country
3.4.2 Europe Biosimilar Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilar Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilar Sales by Region
3.5.2 Asia Pacific Biosimilar Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biosimilar Market Facts & Figures by Country
3.6.1 Latin America Biosimilar Sales by Country
3.6.2 Latin America Biosimilar Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Biosimilar Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilar Sales by Country
3.7.2 Middle East and Africa Biosimilar Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biosimilar Historic Market Analysis by Type
4.1 Global Biosimilar Sales Market Share by Type (2015-2020)
4.2 Global Biosimilar Revenue Market Share by Type (2015-2020)
4.3 Global Biosimilar Price Market Share by Type (2015-2020)
4.4 Global Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Biosimilar Historic Market Analysis by Application
5.1 Global Biosimilar Sales Market Share by Application (2015-2020)
5.2 Global Biosimilar Revenue Market Share by Application (2015-2020)
5.3 Global Biosimilar Price by Application (2015-2020)

6 Company Profiles and Key Figures in Biosimilar Business
6.1 Allergan plc
6.1.1 Corporation Information
6.1.2 Allergan plc Description, Business Overview and Total Revenue
6.1.3 Allergan plc Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Allergan plc Products Offered
6.1.5 Allergan plc Recent Development
6.2 BIOCAD
6.2.1 BIOCAD Biosimilar Production Sites and Area Served
6.2.2 BIOCAD Description, Business Overview and Total Revenue
6.2.3 BIOCAD Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.2.4 BIOCAD Products Offered
6.2.5 BIOCAD Recent Development
6.3 Biocon
6.3.1 Biocon Biosimilar Production Sites and Area Served
6.3.2 Biocon Description, Business Overview and Total Revenue
6.3.3 Biocon Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Biocon Products Offered
6.3.5 Biocon Recent Development
6.4 BioXpress Therapeutics
6.4.1 BioXpress Therapeutics Biosimilar Production Sites and Area Served
6.4.2 BioXpress Therapeutics Description, Business Overview and Total Revenue
6.4.3 BioXpress Therapeutics Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.4.4 BioXpress Therapeutics Products Offered
6.4.5 BioXpress Therapeutics Recent Development
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Biosimilar Production Sites and Area Served
6.5.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.5.3 Boehringer Ingelheim Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Boehringer Ingelheim Products Offered
6.5.5 Boehringer Ingelheim Recent Development
6.6 Celltrion
6.6.1 Celltrion Biosimilar Production Sites and Area Served
6.6.2 Celltrion Description, Business Overview and Total Revenue
6.6.3 Celltrion Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Celltrion Products Offered
6.6.5 Celltrion Recent Development
6.7 Coherus BioSciences
6.6.1 Coherus BioSciences Biosimilar Production Sites and Area Served
6.6.2 Coherus BioSciences Description, Business Overview and Total Revenue
6.6.3 Coherus BioSciences Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Coherus BioSciences Products Offered
6.7.5 Coherus BioSciences Recent Development
6.8 Dr. Reddy’s Laboratories
6.8.1 Dr. Reddy’s Laboratories Biosimilar Production Sites and Area Served
6.8.2 Dr. Reddy’s Laboratories Description, Business Overview and Total Revenue
6.8.3 Dr. Reddy’s Laboratories Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Dr. Reddy’s Laboratories Products Offered
6.8.5 Dr. Reddy’s Laboratories Recent Development
6.9 Genor BioPharma
6.9.1 Genor BioPharma Biosimilar Production Sites and Area Served
6.9.2 Genor BioPharma Description, Business Overview and Total Revenue
6.9.3 Genor BioPharma Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Genor BioPharma Products Offered
6.9.5 Genor BioPharma Recent Development
6.10 Intas Pharmaceuticals Limited
6.10.1 Intas Pharmaceuticals Limited Biosimilar Production Sites and Area Served
6.10.2 Intas Pharmaceuticals Limited Description, Business Overview and Total Revenue
6.10.3 Intas Pharmaceuticals Limited Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Intas Pharmaceuticals Limited Products Offered
6.10.5 Intas Pharmaceuticals Limited Recent Development
6.11 Novartis
6.11.1 Novartis Biosimilar Production Sites and Area Served
6.11.2 Novartis Biosimilar Description, Business Overview and Total Revenue
6.11.3 Novartis Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Novartis Products Offered
6.11.5 Novartis Recent Development
6.12 Pfizer
6.12.1 Pfizer Biosimilar Production Sites and Area Served
6.12.2 Pfizer Biosimilar Description, Business Overview and Total Revenue
6.12.3 Pfizer Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Pfizer Products Offered
6.12.5 Pfizer Recent Development
6.13 Reliance Life Sciences
6.13.1 Reliance Life Sciences Biosimilar Production Sites and Area Served
6.13.2 Reliance Life Sciences Biosimilar Description, Business Overview and Total Revenue
6.13.3 Reliance Life Sciences Biosimilar Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Reliance Life Sciences Products Offered
6.13.5 Reliance Life Sciences Recent Development

7 Biosimilar Manufacturing Cost Analysis
7.1 Biosimilar Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilar
7.4 Biosimilar Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilar Distributors List
8.3 Biosimilar Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Biosimilar Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilar by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Biosimilar by Type (2021-2026)
10.2 Biosimilar Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilar by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Biosimilar by Application (2021-2026)
10.3 Biosimilar Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilar by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Biosimilar by Region (2021-2026)
10.4 North America Biosimilar Estimates and Projections (2021-2026)
10.5 Europe Biosimilar Estimates and Projections (2021-2026)
10.6 Asia Pacific Biosimilar Estimates and Projections (2021-2026)
10.7 Latin America Biosimilar Estimates and Projections (2021-2026)
10.8 Middle East and Africa Biosimilar Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer


List of Tables
Table 1. Global Biosimilar Sales (K g) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Biosimilar Sales (K g) Comparison by Application: 2020 VS 2026
Table 3. Global Biosimilar Market Size by Type (K g) (US$ Million) (2020 VS 2026)
Table 4. Global Key Biosimilar Manufacturers Covered in This Study
Table 5. Global Biosimilar Sales (K g) by Manufacturers (2015-2020)
Table 6. Global Biosimilar Sales Share by Manufacturers (2015-2020)
Table 7. Global Biosimilar Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Biosimilar Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Biosimilar Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Biosimilar Sales Sites and Area Served
Table 11. Manufacturers Biosimilar Product Types
Table 12. Global Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Biosimilar Players
Table 16. Global Biosimilar Sales (K g) by Region (2015-2020)
Table 17. Global Biosimilar Sales Market Share by Region (2015-2020)
Table 18. Global Biosimilar Revenue (Million US$) by Region (2015-2020)
Table 19. Global Biosimilar Revenue Market Share by Region (2015-2020)
Table 20. North America Biosimilar Sales by Country (2015-2020) (K g)
Table 21. North America Biosimilar Sales Market Share by Country (2015-2020)
Table 22. North America Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Biosimilar Revenue Market Share by Country (2015-2020)
Table 24. Europe Biosimilar Sales by Country (2015-2020) (K g)
Table 25. Europe Biosimilar Sales Market Share by Country (2015-2020)
Table 26. Europe Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Biosimilar Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Biosimilar Sales by Region (2015-2020) (K g)
Table 29. Asia Pacific Biosimilar Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Biosimilar Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Biosimilar Revenue Market Share by Region (2015-2020)
Table 32. Latin America Biosimilar Sales by Country (2015-2020) (K g)
Table 33. Latin America Biosimilar Sales Market Share by Country (2015-2020)
Table 34. Latin America Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Biosimilar Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Biosimilar Sales by Country (2015-2020) (K g)
Table 37. Middle East and Africa Biosimilar Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Biosimilar Revenue Market Share by Country (2015-2020)
Table 40. Global Biosimilar Sales (K g) by Type (2015-2020)
Table 41. Global Biosimilar Sales Share by Type (2015-2020)
Table 42. Global Biosimilar Revenue (Million US$) by Type (2015-2020)
Table 43. Global Biosimilar Revenue Share by Type (2015-2020)
Table 44. Global Biosimilar Price (USD/Unit) by Type (2015-2020)
Table 45. Global Biosimilar Sales (K g) by Application (2015-2020)
Table 46. Global Biosimilar Sales Market Share by Application (2015-2020)
Table 47. Global Biosimilar Sales Growth Rate by Application (2015-2020)
Table 48. Allergan plc Biosimilar Corporation Information
Table 49. Allergan plc Description and Business Overview
Table 50. Allergan plc Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Allergan plc Main Product
Table 52. Allergan plc Recent Development
Table 53. BIOCAD Biosimilar Corporation Information
Table 54. BIOCAD Corporation Information
Table 55. BIOCAD Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. BIOCAD Main Product
Table 57. BIOCAD Recent Development
Table 58. Biocon Biosimilar Corporation Information
Table 59. Biocon Corporation Information
Table 60. Biocon Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Biocon Main Product
Table 62. Biocon Recent Development
Table 63. BioXpress Therapeutics Biosimilar Corporation Information
Table 64. BioXpress Therapeutics Corporation Information
Table 65. BioXpress Therapeutics Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. BioXpress Therapeutics Main Product
Table 67. BioXpress Therapeutics Recent Development
Table 68. Boehringer Ingelheim Biosimilar Corporation Information
Table 69. Boehringer Ingelheim Corporation Information
Table 70. Boehringer Ingelheim Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Boehringer Ingelheim Main Product
Table 72. Boehringer Ingelheim Recent Development
Table 73. Celltrion Biosimilar Corporation Information
Table 74. Celltrion Corporation Information
Table 75. Celltrion Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Celltrion Main Product
Table 77. Celltrion Recent Development
Table 78. Coherus BioSciences Biosimilar Corporation Information
Table 79. Coherus BioSciences Corporation Information
Table 80. Coherus BioSciences Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Coherus BioSciences Main Product
Table 82. Coherus BioSciences Recent Development
Table 83. Dr. Reddy’s Laboratories Biosimilar Corporation Information
Table 84. Dr. Reddy’s Laboratories Corporation Information
Table 85. Dr. Reddy’s Laboratories Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Dr. Reddy’s Laboratories Main Product
Table 87. Dr. Reddy’s Laboratories Recent Development
Table 88. Genor BioPharma Biosimilar Corporation Information
Table 89. Genor BioPharma Corporation Information
Table 90. Genor BioPharma Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Genor BioPharma Main Product
Table 92. Genor BioPharma Recent Development
Table 93. Intas Pharmaceuticals Limited Biosimilar Corporation Information
Table 94. Intas Pharmaceuticals Limited Corporation Information
Table 95. Intas Pharmaceuticals Limited Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Intas Pharmaceuticals Limited Main Product
Table 97. Intas Pharmaceuticals Limited Recent Development
Table 98. Novartis Biosimilar Corporation Information
Table 99. Novartis Corporation Information
Table 100. Novartis Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Novartis Main Product
Table 102. Novartis Recent Development
Table 103. Pfizer Biosimilar Corporation Information
Table 104. Pfizer Corporation Information
Table 105. Pfizer Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Pfizer Main Product
Table 107. Pfizer Recent Development
Table 108. Reliance Life Sciences Biosimilar Corporation Information
Table 109. Reliance Life Sciences Corporation Information
Table 110. Reliance Life Sciences Biosimilar Sales (K g), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Reliance Life Sciences Main Product
Table 112. Reliance Life Sciences Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Biosimilar Distributors List
Table 116. Biosimilar Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Biosimilar Sales (K g) Forecast by Type (2021-2026)
Table 121. Global Biosimilar Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Biosimilar Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Biosimilar Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Biosimilar Sales (K g) Forecast by Application (2021-2026)
Table 125. Global Biosimilar Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Biosimilar Sales (K g) Forecast by Region (2021-2026)
Table 127. Global Biosimilar Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Biosimilar Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Biosimilar Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Biosimilar
Figure 2. Global Biosimilar Sales Market Share by Type: 2020 VS 2026
Figure 3. Human Growth Hormones Product Picture
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Insulin Product Picture
Figure 6. Peptides Product Picture
Figure 7. Erythropoietin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Biosimilar Consumption Market Share by Application: 2020 VS 2026
Figure 10. Oncology
Figure 11. Chronic and Autoimmune Diseases
Figure 12. Growth Hormone Deficiency
Figure 13. Infectious Diseases
Figure 14. Others
Figure 15. Global Biosimilar Market Size 2015-2026 (US$ Million)
Figure 16. Global Biosimilar Sales Capacity (K g) (2015-2026)
Figure 17. Global Biosimilar Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Biosimilar Sales Share by Manufacturers in 2020
Figure 19. Global Biosimilar Revenue Share by Manufacturers in 2019
Figure 20. The Global 5 and 10 Largest Players: Market Share by Biosimilar Revenue in 2019
Figure 21. Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Biosimilar Sales Market Share by Region (2015-2020)
Figure 23. Global Biosimilar Sales Market Share by Region in 2019
Figure 24. Global Biosimilar Revenue Market Share by Region (2015-2020)
Figure 25. Global Biosimilar Revenue Market Share by Region in 2019
Figure 26. North America Biosimilar Sales Market Share by Country in 2019
Figure 27. North America Biosimilar Revenue Market Share by Country in 2019
Figure 28. U.S. Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 29. U.S. Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Canada Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 31. Canada Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. Europe Biosimilar Sales Market Share by Country in 2019
Figure 33. Europe Biosimilar Revenue Market Share by Country in 2019
Figure 34. Germany Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 35. Germany Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. France Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 37. France Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. U.K. Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 39. U.K. Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Italy Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 41. Italy Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Russia Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 43. Russia Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Asia Pacific Biosimilar Sales Market Share by Region in 2019
Figure 45. Asia Pacific Biosimilar Revenue Market Share by Region in 2019
Figure 46. China Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 47. China Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Japan Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 49. Japan Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. South Korea Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 51. South Korea Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. India Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 53. India Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Australia Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 55. Australia Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Taiwan Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 57. Taiwan Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Indonesia Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 59. Indonesia Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Thailand Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 61. Thailand Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Malaysia Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 63. Malaysia Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Philippines Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 65. Philippines Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Vietnam Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 67. Vietnam Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Latin America Biosimilar Sales Market Share by Country in 2019
Figure 69. Latin America Biosimilar Revenue Market Share by Country in 2019
Figure 70. Mexico Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 71. Mexico Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Brazil Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 73. Brazil Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Argentina Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 75. Argentina Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Middle East and Africa Biosimilar Sales Market Share by Country in 2019
Figure 77. Middle East and Africa Biosimilar Revenue Market Share by Country in 2019
Figure 78. Turkey Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 79. Turkey Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Saudi Arabia Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 81. Saudi Arabia Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. U.A.E Biosimilar Sales Growth Rate (2015-2020) (K g)
Figure 83. U.A.E Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Sales Market Share of Biosimilar by Type (2015-2020)
Figure 85. Sales Market Share of Biosimilar by Type in 2019
Figure 86. Revenue Share of Biosimilar by Type (2015-2020)
Figure 87. Revenue Market Share of Biosimilar by Type in 2019
Figure 88. Global Biosimilar Sales Growth by Type (2015-2020) (K g)
Figure 89. Global Biosimilar Sales Market Share by Application (2015-2020)
Figure 90. Global Biosimilar Sales Market Share by Application in 2019
Figure 91. Global Revenue Share of Biosimilar by Application (2015-2020)
Figure 92. Global Revenue Share of Biosimilar by Application in 2020
Figure 93. Allergan plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. BIOCAD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. BioXpress Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Coherus BioSciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Genor BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Intas Pharmaceuticals Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Reliance Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Biosimilar
Figure 108. Manufacturing Process Analysis of Biosimilar
Figure 109. Biosimilar Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Biosimilar Sales (K g) and Growth Rate Forecast (2021-2026)
Figure 114. North America Biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Biosimilar Sales (K g) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Biosimilar Sales (K g) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Biosimilar Sales (K g) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Biosimilar Sales (K g) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Biosimilar Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

Biosimilar  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com